|
1.
|
Wang ZQ, Stingl L, Morrison C, et al: PARP
is important for genomic stability but dispensable in apoptosis.
Genes Dev. 11:2347–2358. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Dantzer F, de La Rubia G, Menissier-De
Murcia J, Hostomsky Z, de Murcia G and Schreiber V: Base excision
repair is impaired in mammalian cells lacking Poly(ADP-ribose)
polymerase-1. Biochemistry. 39:7559–7569. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Trucco C, Oliver FJ, de Murcia G and
Menissier-de Murcia J: DNA repair defect in poly(ADP-ribose)
polymerase-deficient cell lines. Nucleic Acids Res. 26:2644–2649.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Menissier de Murcia J, Ricoul M, Tartier
L, et al: Functional interaction between PARP-1 and PARP-2 in
chromosome stability and embryonic development in mouse. EMBO J.
22:2255–2263. 2003.PubMed/NCBI
|
|
5.
|
Ame JC, Rolli V, Schreiber V, et al:
PARP-2, a novel mammalian DNA damage-dependent poly(ADP-ribose)
polymerase. J Biol Chem. 274:17860–17868. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Juarez-Salinas H, Sims JL and Jacobson MK:
Poly(ADP-ribose) levels in carcinogen-treated cells. Nature.
282:740–741. 1979. View
Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Brochu G, Duchaine C, Thibeault L, Lagueux
J, Shah GM and Poirier GG: Mode of action of poly(ADP-ribose)
glycohydrolase. Biochim Biophys Acta. 1219:342–350. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Lin W, Ame JC, Aboul-Ela N, Jacobson EL
and Jacobson MK: Isolation and characterization of the cDNA
encoding bovine poly(ADP-ribose) glycohydrolase. J Biol Chem.
272:11895–11901. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Schreiber V, Ame JC, Dolle P, et al:
Poly(ADP-ribose) polymerase-2 (PARP-2) is required for efficient
base excision DNA repair in association with PARP-1 and XRCC1. J
Biol Chem. 277:23028–23036. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Dantzer F, Schreiber V, Niedergang C, et
al: Involvement of poly(ADP-ribose) polymerase in base excision
repair. Biochimie. 81:69–75. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Sims JL, Berger SJ and Berger NA:
Poly(ADP-ribose) Polymerase inhibitors preserve nicotinamide
adenine dinucleo-tide and adenosine 5′-triphosphate pools in
DNA-damaged cells: mechanism of stimulation of unscheduled DNA
synthesis. Biochemistry. 22:5188–5194. 1983.PubMed/NCBI
|
|
12.
|
Andrabi SA, Kim NS, Yu SW, et al:
Poly(ADP-ribose) (PAR) polymer is a death signal. Proc Natl Acad
Sci USA. 103:18308–18313. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Jacobson EL, Smith JY, Wielckens K, Hilz H
and Jacobson MK: Cellular recovery of dividing and confluent
C3H10T1/2 cells from N-methyl-N’-nitro-N-nitrosoguanidine in the
presence of ADP-ribosylation inhibitors. Carcinogenesis. 6:715–718.
1985.PubMed/NCBI
|
|
14.
|
Park SD, Kim CG and Kim MG: Inhibitors of
poly(ADP-ribose) polymerase enhance DNA strand breaks, excision
repair, and sister chromatid exchanges induced by alkylating
agents. Environ Mutagen. 5:515–525. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Boulton S, Pemberton LC, Porteous JK, et
al: Potentiation of temozolomide-induced cytotoxicity: a
comparative study of the biological effects of poly(ADP-ribose)
polymerase inhibitors. Br J Cancer. 72:849–856. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Rankin PW, Jacobson EL, Benjamin RC, Moss
J and Jacobson MK: Quantitative studies of inhibitors of
ADP-ribosylation in vitro and in vivo. J Biol Chem. 264:4312–4317.
1989.PubMed/NCBI
|
|
17.
|
Banasik M, Komura H, Shimoyama M and Ueda
K: Specific inhibitors of poly(ADP-ribose) synthetase and
mono(ADP-ribosyl)transferase. J Biol Chem. 267:1569–1575.
1992.PubMed/NCBI
|
|
18.
|
Kjellen E, Pero RW, Brun E, et al: A phase
I/II evaluation of metoclopramide as a radiosensitiser in patients
with inoperable squamous cell carcinoma of the lung. Eur J Cancer.
31A:2196–2202. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Rouleau M, Patel A, Hendzel MJ, Kaufmann
SH and Poirier GG: PARP inhibition: PARP1 and beyond. Nat Rev
Cancer. 10:293–301. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Farmer H, McCabe N, Lord CJ, et al:
Targeting the DNA repair defect in BRCA mutant cells as a
therapeutic strategy. Nature. 434:917–921. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Bryant HE, Schultz N, Thomas HD, et al:
Specific killing of BRCA2-deficient tumours with inhibitors of
poly(ADP-ribose) polymerase. Nature. 434:913–917. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Donawho CK, Luo Y, Penning TD, et al:
ABT-888, an orally active poly(ADP-ribose) polymerase inhibitor
that potentiates DNA-damaging agents in preclinical tumor models.
Clin Cancer Res. 13:2728–2737. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Norquist B, Wurz KA, Pennil CC, et al:
Secondary somatic mutations restoring BRCA1/2 predict chemotherapy
resistance in hereditary ovarian carcinomas. J Clin Oncol.
29:3008–3015. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Hutchinson L: Targeted therapies: PARP
inhibitor olaparib is safe and effective in patients with BRCA1 and
BRCA2 mutations. Nat Rev Clin Oncol. 7:5492010. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Tutt A, Robson M, Garber JE, et al: Oral
poly(ADP-ribose) polymerase inhibitor olaparib in patients with
BRCA1 or BRCA2 mutations and advanced breast cancer: a
proof-of-concept trial. Lancet. 376:235–244. 2010. View Article : Google Scholar
|
|
26.
|
Audeh MW, Carmichael J, Penson RT, et al:
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients
with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a
proof-of-concept trial. Lancet. 376:245–251. 2010. View Article : Google Scholar
|
|
27.
|
Fujihara H, Ogino H, Maeda D, et al:
Poly(ADP-ribose) glycohydrolase deficiency sensitizes mouse ES
cells to DNA damaging agents. Curr Cancer Drug Targets. 9:953–962.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Hanai S, Kanai M, Ohashi S, et al: Loss of
poly(ADP-ribose) glycohydrolase causes progressive
neurodegeneration in Drosophila melanogaster. Proc Natl Acad
Sci USA. 101:82–86. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Koh DW, Lawler AM, Poitras MF, et al:
Failure to degrade poly(ADP-ribose) causes increased sensitivity to
cytotoxicity and early embryonic lethality. Proc Natl Acad Sci USA.
101:17699–17704. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Min W, Cortes U, Herceg Z, Tong WM and
Wang ZQ: Deletion of the nuclear isoform of poly(ADP-ribose)
glycohydrolase (PARG) reveals its function in DNA repair, genomic
stability and tumorigenesis. Carcinogenesis. 31:2058–2065. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Ame JC, Fouquerel E, Gauthier LR, et al:
Radiation-induced mitotic catastrophe in PARG-deficient cells. J
Cell Sci. 122:1990–2002. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Tentori L, Leonetti C, Scarsella M, et al:
Poly(ADP-ribose) glycohydrolase inhibitor as chemosensitiser of
malignant melanoma for temozolomide. Eur J Cancer. 41:2948–2957.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Fathers C, Drayton RM, Solovieva S and
Bryant HE: Inhibition of poly(ADP-ribose) glycohydrolase (PARG)
specifically kills BRCA2-deficient tumor cells. Cell Cycle.
11:990–997. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Kickhoefer VA, Siva AC, Kedersha NL, et
al: The 193-kD vault protein, VPARP, is a novel poly(ADP-ribose)
polymerase. J Cell Biol. 146:917–928. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Smith S, Giriat I, Schmitt A and de Lange
T: Tankyrase, a poly(ADP-ribose) polymerase at human telomeres.
Science. 282:1484–1487. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Takahashi K, Greenberg JH, Jackson P,
Maclin K and Zhang J: Neuroprotective effects of inhibiting
poly(ADP-ribose) synthetase on focal cerebral ischemia in rats. J
Cereb Blood Flow Metab. 17:1137–1142. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Abdelkarim GE, Gertz K, Harms C, et al:
Protective effects of PJ34, a novel, potent inhibitor of
poly(ADP-ribose) polymerase (PARP) in in vitro and in
vivo models of stroke. Int J Mol Med. 7:255–260. 2001.
|
|
38.
|
Shieh WM, Ame JC, Wilson MV, et al:
Poly(ADP-ribose) polymerase null mouse cells synthesize ADP-ribose
polymers. J Biol Chem. 273:30069–30072. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
39.
|
Pinsky SD, Tew KD, Smulson ME and Woolley
PV III: Modification of L1210 cell nuclear proteins by
1-methyl-1-nitrosourea and 1-methyl-3-nitro-1-nitrosoguanidine.
Cancer Res. 39:923–928. 1979.PubMed/NCBI
|
|
40.
|
Kim MY, Mauro S, Gevry N, Lis JT and Kraus
WL: NAD+-dependent modulation of chromatin structure and
transcription by nucleosome binding properties of PARP-1. Cell.
119:803–814. 2004.
|
|
41.
|
Zhou Y, Feng X and Koh DW: Synergistic
cytotoxicity of N-methyl-N’-nitro-N-nitrosoguanidine and absence of
poly(ADP-ribose) glycohydrolase involves chromatin decondensation.
Int J Oncol. 39:121–127. 2011.
|
|
42.
|
Zhou Y, Feng X and Koh DW: Enhanced DNA
accessibility and increased DNA damage induced by the absence of
poly(ADP-ribose) hydrolysis. Biochemistry. 49:7360–7366. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
43.
|
Zhou Y, Feng X and Koh DW: Activation of
cell death mediated by apoptosis-inducing factor due to the absence
of poly(ADP-ribose) glycohydrolase. Biochemistry. 50:2850–2859.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
44.
|
Jacobson MK and Jacobson EL: Discovering
new ADP-ribose polymer cycles: protecting the genome and more.
Trends Biochem Sci. 24:415–417. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
45.
|
Feng X, Zhou Y, Proctor AM, Hopkins MM,
Liu M and Koh DW: Silencing of apoptosis-inducing factor and
poly(ADP-ribose) glycohydrolase reveals novel roles in breast
cancer cell death after chemotherapy. Mol Cancer. 11:482012.
View Article : Google Scholar : PubMed/NCBI
|
